Efficacy of consensus interferon in the treatment of chronic hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 12, 2000, Pages 1418-1423

  Kao, Jia Horng ^a   Chen, Pei Jer ^a   Lai, Ming Yang ^a   Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Consensus interferon; Hepatitis C virus; Sustained response

Indexed keywords

AMINOTRANSFERASE; CONSENSUS INTERFERON; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; BODY WEIGHT; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VIREMIA;

EID: 84984559279     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02371.x     Document Type: Article

References (25)

1. Hepatitis C
2. Management of hepatitis C
3. The treatment of chronic viral hepatitis
4. The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon
5. Production, characterization and biological effects of recombinant DNA derived human IFN-alfa and IFN-gamma analogs
6. Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial
7. Re-treatment of chronic hepatitis C with consensus interferon
8. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon
9. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C
10. Classification of chronic hepatitis: Diagnosis, grading and staging
11. A one-year trial of lamivudine for chronic hepatitis B
12. Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections
13. Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: No correlation with viral genotypes 1b, 2a, and 2b
14. Molecular methods for hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection: Implications for occupational health practice
15. Quasispecies nature of hepatitis C virus and response to alpha interferon: Significance as a predictor of direct response to interferon
16. Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis C
17. GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer
18. Prevalence and implication of TT virus infection: Minimal role in patients with non-A∼G hepatitis in Taiwan
19. Combination therapy of ribavirin plus interferon-α versus interferon-α alone for chronic hepatitis C
20. Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon alpha alone
21. TT virus infection in patients with chronic hepatitis B or C: Influence on clinical, histological and virological features
22. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy
23. Long term histologic improvement and loss of detectable intrahepatic HCV-RNA in patients with chronic hepatitis C and sustained response to interferon therapy
24. Interferon alfa-2b monotherapy versus interferon alfa-2b plus ribavirin as initial treatment for chronic hepatitis C: Results of a US multi-center randomized controlled trial
25. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia